Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.92 -0.43 (-2.80%)
As of: Oct 1, 2026 · 2:00 PM EDT

Cullinan Therapeutics (CGEM) Return on Equity [ROE] (2020 - 2026)

Updated

Cullinan Therapeutics' Return on Equity [ROE] came in at -59.51% for Q2 2026, down 19.90 percentage points from -39.61% a year earlier and down 2.46 percentage points from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Cullinan Therapeutics' Return on Equity [ROE] was -44.02%, down 11.92 percentage points from FY2024.

  • Return on Equity [ROE] has declined in each of the last three years, with a four-year change of -22.45 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Equity [ROE] was -32.10% in FY2024 (-0.73 pp), -31.37% in FY2023 (-54.11 pp), 22.74% in FY2022 (+44.31 pp) and -21.57% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
  • Year-over-year, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -11.31 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2022 (a gain of 34.98 percentage points), and the weakest in Q4 2023 (a drop of 53.10 percentage points).
  • Business Quant data shows CGEM's Return on Equity [ROE] at -57.05% (Q1 2026), -51.13% (Q4 2025) and -45.96% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Cullinan Therapeutics 987.71 Mn 987.71 Mn - -59.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.51%
Mar 31, 2026 -57.05%
Dec 31, 2025 -51.13%
Sep 30, 2025 -45.96%
Jun 30, 2025 -39.61%
Mar 31, 2025 -31.30%
Dec 31, 2024 -27.51%
Sep 30, 2024 -22.66%
Jun 30, 2024 -26.64%
Mar 31, 2024 -30.54%
Dec 31, 2023 -33.62%
Sep 30, 2023 -32.35%
Jun 30, 2023 -28.89%
Mar 31, 2023 12.53%
Dec 31, 2022 19.48%
Sep 30, 2022 17.15%
Jun 30, 2022 21.23%
Mar 31, 2022 -19.36%
Dec 31, 2021 -15.50%
Sep 30, 2021 -13.80%
API Access

Cullinan Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CGEM&period=max&api_key=YOUR_API_KEY